ALPHA TEKNOVA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
ALPHA TEKNOVA, INC. (TKNO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $1.84 per share for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2024-11-08
- ALPHA TEKNOVA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2024-09-30 was $1.84, a 222.81% increase year-over-year.
- ALPHA TEKNOVA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2024-03-31 was $1.24, a 45.85% decline year-over-year.
- ALPHA TEKNOVA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-09-30 was $0.57, a 70.77% decline year-over-year.
- ALPHA TEKNOVA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-06-30 was $0.81, a 85.11% decline year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month |
|---|---|---|---|
| 2024-09-30 | $1.84 10-Q · filed 2024-11-08 | $1.24 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $1.24 10-Q · filed 2024-08-13 | ||
| 2024-03-31 | $1.24 10-Q · filed 2024-05-13 | ||
| 2023-09-30 | $0.57 10-Q · filed 2024-11-08 | $2.12 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $0.81 10-Q · filed 2024-08-13 | $2.28 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $2.29 10-Q · filed 2024-05-13 | ||
| 2022-09-30 | $1.95 10-Q · filed 2022-11-14 | $5.23 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $5.44 10-Q · filed 2022-08-11 | $5.48 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $5.48 10-Q · filed 2022-05-12 | ||
| 2021-09-30 | $9.42 10-Q · filed 2022-11-14 | $5.62 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $5.42 10-Q · filed 2022-08-11 | $4.52 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $3.19 10-Q · filed 2022-05-12 | ||
| 2020-09-30 | $2.13 10-Q · filed 2021-11-12 | $2.13 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |